J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-86, 2015.
DOI : 10.1002/ijc.29210

S. Johnston, New Strategies in Estrogen Receptor-Positive Breast Cancer, Clinical Cancer Research, vol.16, issue.7, pp.1979-87, 2010.
DOI : 10.1158/1078-0432.CCR-09-1823

B. Fisher, S. Anderson, C. Redmond, N. Wolmark, D. Wickerham et al., Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer, New England Journal of Medicine, vol.333, issue.22, pp.1456-61, 1995.
DOI : 10.1056/NEJM199511303332203

A. Howell, Adjuvant aromatase inhibitors for breast cancer, The Lancet, vol.366, issue.9484, pp.431-434, 2005.
DOI : 10.1016/S0140-6736(05)67036-5

R. Silvestrini, M. Daidone, A. Luisi, P. Boracchi, M. Mezzetti et al., Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer., Journal of Clinical Oncology, vol.13, issue.3, pp.697-704, 1995.
DOI : 10.1200/JCO.1995.13.3.697

K. Polyak and P. Vogt, Progress in breast cancer research, Proceedings of the National Academy of Sciences, vol.109, issue.8, pp.2715-2722, 2012.
DOI : 10.1073/pnas.1201091109

V. Jordan, O. Malley, and B. , Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast Cancer, Journal of Clinical Oncology, vol.25, issue.36, pp.5815-5839, 2007.
DOI : 10.1200/JCO.2007.11.3886

Z. Wang, X. Zhang, P. Shen, B. Loggie, Y. Chang et al., Identification, cloning, and expression of human estrogen receptor-??36, a novel variant of human estrogen receptor-??66, Biochemical and Biophysical Research Communications, vol.336, issue.4, pp.1023-1030, 2005.
DOI : 10.1016/j.bbrc.2005.08.226

S. Denger, G. Reid, M. Kos, G. Flouriot, D. Parsch et al., ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins, Mol Endocrinol, vol.15, issue.12, pp.2064-77, 2001.

A. Murphy, P. Guyre, C. Wira, and P. Pioli, Estradiol Regulates Expression of Estrogen Receptor ER??46 in Human Macrophages, PLoS ONE, vol.176, issue.5, p.5539, 2009.
DOI : 10.1371/journal.pone.0005539.s001

L. Li, M. Haynes, and J. Bender, Plasma membrane localization and function of the estrogen receptor ?? variant (ER46) in human endothelial cells, Proceedings of the National Academy of Sciences, vol.100, issue.8, pp.4807-4819, 2003.
DOI : 10.1073/pnas.0831079100

H. Jiang, R. Teng, Q. Wang, X. Zhang, H. Wang et al., Estrogen receptor alpha variant ERalpha46 mediates growth inhibition and apoptosis of human HT-29 colon adenocarcinoma cells in the presence of 17beta- oestradiol, Chin Med J (Engl), vol.121, issue.11, pp.1025-1056, 2008.

C. Klinge, K. Riggs, N. Wickramasinghe, C. Emberts, D. Mcconda et al., Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription, Molecular and Cellular Endocrinology, vol.323, issue.2, pp.268-76, 2010.
DOI : 10.1016/j.mce.2010.03.013

G. Flouriot, H. Brand, S. Denger, R. Metivier, M. Kos et al., Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1, The EMBO Journal, vol.19, issue.17, pp.4688-700, 2000.
DOI : 10.1093/emboj/19.17.4688

Y. Maaroufi, M. Lacroix, L. Lespagnard, F. Journe, D. Larsimont et al., Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis, Breast Cancer Research, vol.325, issue.6, pp.444-54, 2000.
DOI : 10.1038/325075a0

P. Barraille, P. Chinestra, F. Bayard, and J. Faye, Alternative Initiation of Translation Accounts for a 67/45 kDa Dimorphism of the Human Estrogen Receptor ER??, Biochemical and Biophysical Research Communications, vol.257, issue.1, pp.84-92, 1999.
DOI : 10.1006/bbrc.1999.0334

G. Penot, L. Peron, C. Merot, Y. Grimaud-fanouillere, E. Ferriere et al., The Human Estrogen Receptor-?? Isoform hER??46 Antagonizes the Proliferative Influence of hER??66 in MCF7 Breast Cancer Cells, Endocrinology, vol.146, issue.12, pp.5474-84, 2005.
DOI : 10.1210/en.2005-0866

A. Billon-gales, C. Fontaine, C. Filipe, V. Douin-echinard, M. Fouque et al., The transactivating function 1 of estrogen receptor ?? is dispensable for the vasculoprotective actions of 17??-estradiol, Proceedings of the National Academy of Sciences, vol.106, issue.6, pp.2053-2061, 2009.
DOI : 10.1073/pnas.0808742106
URL : https://hal.archives-ouvertes.fr/hal-00369691

A. Abot, C. Fontaine, I. Raymond-letron, G. Flouriot, M. Adlanmerini et al., The AF-1??activation function of estrogen receptor alpha is necessary and sufficient for uterine epithelial cell proliferation in vivo, Annales d'Endocrinologie, vol.74, issue.4, pp.2222-2255, 2013.
DOI : 10.1016/j.ando.2013.07.096

S. Jozan, A. Julia, A. Carretie, N. Eche, V. Maisongrosse et al., 65 and 47 kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness, Breast Cancer Research and Treatment, vol.99, issue.2, pp.103-112, 1991.
DOI : 10.1007/BF01980940

G. Reid, M. Hubner, R. Metivier, H. Brand, S. Denger et al., Cyclic, Proteasome-Mediated Turnover of Unliganded and Liganded ER?? on Responsive Promoters Is an Integral Feature of Estrogen Signaling, Molecular Cell, vol.11, issue.3, pp.695-707, 2003.
DOI : 10.1016/S1097-2765(03)00090-X

R. Metivier, G. Penot, R. Carmouche, M. Hubner, G. Reid et al., Transcriptional complexes engaged by apo-estrogen receptor-?? isoforms have divergent outcomes, The EMBO Journal, vol.983, issue.18, pp.3653-66, 2004.
DOI : 10.1101/GAD.13.18.2388

C. Elston and I. Ellis, pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, vol.9, issue.5, pp.403-413, 1991.
DOI : 10.1016/0277-5379(88)90171-X

N. Ainaoui, F. Hantelys, E. Renaud-gabardos, M. Bunel, F. Lopez et al., Promoter-Dependent Translation Controlled by p54nrb and hnRNPM during Myoblast Differentiation, PLOS ONE, vol.280, issue.38, p.136466, 2015.
DOI : 10.1371/journal.pone.0136466.s004
URL : http://doi.org/10.1371/journal.pone.0136466

A. Koppen, R. Houtman, D. Pijnenburg, E. Jeninga, R. Ruijtenbeek et al., Nuclear Receptor-Coregulator Interaction Profiling Identifies TRIP3 as a Novel Peroxisome Proliferator-activated Receptor ?? Cofactor, Molecular & Cellular Proteomics, vol.8, issue.10, pp.2212-2238, 2009.
DOI : 10.1074/mcp.M900209-MCP200

R. Houtman, R. De-leeuw, M. Rondaij, D. Melchers, D. Verwoerd et al., Serine-305 Phosphorylation Modulates Estrogen Receptor Alpha Binding to a Coregulator Peptide Array, with Potential Application in Predicting Responses to Tamoxifen, Molecular Cancer Therapeutics, vol.11, issue.4, pp.805-821, 2012.
DOI : 10.1158/1535-7163.MCT-11-0855

T. Al-saati, S. Clamens, E. Cohen-knafo, J. Faye, H. Prats et al., Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER), International Journal of Cancer, vol.155, issue.4, pp.651-655, 1993.
DOI : 10.1002/ijc.2910550423

M. Cheang, D. Treaba, C. Speers, I. Olivotto, C. Bajdik et al., Immunohistochemical Detection Using the New Rabbit Monoclonal Antibody SP1 of Estrogen Receptor in Breast Cancer Is Superior to Mouse Monoclonal Antibody 1D5 in Predicting Survival, Journal of Clinical Oncology, vol.24, issue.36, pp.5637-5681, 2006.
DOI : 10.1200/JCO.2005.05.4155

G. Bogina, G. Zamboni, A. Sapino, L. Bortesi, M. Marconi et al., Comparison of Anti???Estrogen Receptor Antibodies SP1, 6F11, and 1D5 in Breast Cancer, American Journal of Clinical Pathology, vol.138, issue.5, pp.697-702, 2012.
DOI : 10.1309/AJCPLX0QJROV2IJG

K. Madeira, R. Daltoe, G. Sirtoli, L. Rezende, A. Carvalho et al., Comparison of immunohistochemical analysis with estrogen receptor SP1 and 1D5 monoclonal antibodies in breast cancer, Pathology - Research and Practice, vol.208, issue.11, pp.657-61, 2012.
DOI : 10.1016/j.prp.2012.07.010

M. Faye and M. Holcik, The role of IRES trans-acting factors in carcinogenesis, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1849, issue.7, pp.887-97, 2015.
DOI : 10.1016/j.bbagrm.2014.09.012

G. Leprivier, B. Rotblat, D. Khan, J. E. Sorensen, and P. , Stress-mediated translational control in cancer cells, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1849, issue.7, pp.845-60, 2015.
DOI : 10.1016/j.bbagrm.2014.11.002

Y. Bu and J. Diehl, PERK Integrates Oncogenic Signaling and Cell Survival During Cancer Development, Journal of Cellular Physiology, vol.27, issue.10, pp.2088-96, 2016.
DOI : 10.1002/jcp.25336

M. Holcik and N. Sonenberg, Translational control in stress and apoptosis, Nature Reviews Molecular Cell Biology, vol.8, issue.4, pp.318-345, 2005.
DOI : 10.1038/nrm1618

J. Quintin, L. Peron, C. Palierne, G. Bizot, M. Cunha et al., Dynamic Estrogen Receptor Interactomes Control Estrogen-Responsive Trefoil Factor (TFF) Locus Cell-Specific Activities, Molecular and Cellular Biology, vol.34, issue.13, pp.2418-2454, 2014.
DOI : 10.1128/MCB.00918-13
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054307

J. Carroll, C. Meyer, J. Song, W. Li, T. Geistlinger et al., Genome-wide analysis of estrogen receptor binding sites, Nature Genetics, vol.8, issue.11, pp.1289-97, 2006.
DOI : 10.1038/ng1901

R. Clarke and N. Brunner, Acquired estrogen independence and antiestrogen resistance in breast cancer, Trends in Endocrinology & Metabolism, vol.7, issue.8, pp.291-301, 1996.
DOI : 10.1016/S1043-2760(96)00127-0

Y. Merot, R. Metivier, G. Penot, D. Manu, C. Saligaut et al., The Relative Contribution Exerted by AF-1 and AF-2 Transactivation Functions in Estrogen Receptor ?? Transcriptional Activity Depends upon the Differentiation Stage of the Cell, Journal of Biological Chemistry, vol.279, issue.25, pp.26184-91, 2004.
DOI : 10.1074/jbc.M402148200
URL : https://hal.archives-ouvertes.fr/hal-00295059

E. Fox, J. Andrade, and M. Shupnik, Novel actions of estrogen to promote proliferation: Integration of cytoplasmic and nuclear pathways, Steroids, vol.74, issue.7, pp.622-629, 2009.
DOI : 10.1016/j.steroids.2008.10.014

L. Romancer, M. Poulard, C. Cohen, P. Sentis, S. Renoir et al., Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors, Endocrine Reviews, vol.32, issue.5, pp.597-622, 2011.
DOI : 10.1210/er.2010-0016

P. Yi, Z. Wang, Q. Feng, G. Pintilie, C. Foulds et al., Structure of a Biologically Active Estrogen Receptor-Coactivator Complex on DNA, Molecular Cell, vol.57, issue.6, pp.1047-58, 2015.
DOI : 10.1016/j.molcel.2015.01.025

L. Johansson, J. Thomsen, A. Damdimopoulos, G. Spyrou, J. Gustafsson et al., The Orphan Nuclear Receptor SHP Inhibits Agonist-dependent Transcriptional Activity of Estrogen Receptors ER?? and ER??, Journal of Biological Chemistry, vol.274, issue.1, pp.345-53, 1999.
DOI : 10.1074/jbc.274.1.345

L. Hui, L. Bakiri, A. Mairhorfer, N. Schweifer, C. Haslinger et al., p38?? suppresses normal and cancer cell proliferation by antagonizing the JNK???c-Jun pathway, Nature Genetics, vol.15, issue.6, pp.741-750, 2007.
DOI : 10.1038/sj.onc.1204494

C. Hansen, J. Bartek, and S. Jensen, A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3, Cell Cycle, vol.7, issue.3, pp.325-359, 2008.
DOI : 10.4161/cc.7.3.5354

M. Nakamura, K. Shimada, and N. Konishi, The role of HRK gene in human cancer, Oncogene, vol.18, issue.1, pp.105-113, 2008.
DOI : 10.1126/science.290.5493.989

A. Accardo, E. Trevisiol, A. Cerf, C. Thibault, H. Laurell et al., Versatile multicharacterization platform involving tailored superhydrophobic SU-8 micropillars for the investigation of breast cancer estrogen receptor isoforms, Journal of Vacuum Science & Technology B, Nanotechnology and Microelectronics: Materials, Processing, Measurement, and Phenomena, vol.34, issue.6, 2016.
DOI : 10.1116/1.4962382

T. Horigome, F. Ogata, T. Golding, and K. Korach, Estradiol-Stimulated Proteolytic Cleavage of the Estrogen Receptor in Mouse Uterus, Endocrinology, vol.123, issue.5, pp.2540-2548, 1988.
DOI : 10.1210/endo-123-5-2540

M. Bushell, M. Stoneley, Y. Kong, T. Hamilton, K. Spriggs et al., Polypyrimidine Tract Binding Protein Regulates IRES-Mediated Gene Expression during Apoptosis, Molecular Cell, vol.23, issue.3, pp.401-413, 2006.
DOI : 10.1016/j.molcel.2006.06.012
URL : http://doi.org/10.1016/j.molcel.2006.06.012

F. Morfoisse, A. Kuchnio, C. Frainay, A. Gomez-brouchet, M. Delisle et al., Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1??-Independent Translation-Mediated Mechanism, Cell Reports, vol.6, issue.1, pp.155-67, 2014.
DOI : 10.1016/j.celrep.2013.12.011

P. Hanson, H. Zhang, M. Hemida, X. Ye, Y. Qiu et al., IRES-Dependent Translational Control during Virus-Induced Endoplasmic Reticulum Stress and Apoptosis, Frontiers in Microbiology, vol.3, p.92, 2012.
DOI : 10.3389/fmicb.2012.00092
URL : http://doi.org/10.3389/fmicb.2012.00092

D. Pappin, P. Hojrup, and A. Bleasby, Rapid identification of proteins by peptide-mass fingerprinting, Current Biology, vol.3, issue.6, pp.327-359, 1993.
DOI : 10.1016/0960-9822(93)90195-T